Overview
Evidence-based recommendations on transperineal biopsy for diagnosing prostate cancer.
Last reviewed: 1 June 2023
Diagnostics guidance 54 has been migrated to HealthTech guidance 680.
Next review: This guidance will be reviewed if there is new evidence that is likely to change the recommendations.